Search Results

Rebastinib 2 mg  | Purity Not Available

TargetMol

DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 nM), also inhibits LYN, SRC, HCK, FGR, FLT3, KDR, and Tie-2, and low activity to c-Kit. Rebastinib aimed at the Angiopoietin2-Tie2 pathway.

More Information Supplier Page

Macitentan 100 mg  | Purity Not Available

TargetMol

Macitentan is an endothelin receptor antagonist that is used in the therapy of pulmonary arterial hypertension (PAH).

More Information Supplier Page

Pimecrolimus 100 mg  | Purity Not Available

TargetMol

Pimecrolimus, a calcineurin inhibitor immunosuppressant, binds to the receptor macrophilin-12 (FKBP-12) forming a complex that blocks the calcium-dependent signal transduction cascade mediated by calcineurin.

More Information Supplier Page

Pimecrolimus 200 mg  | Purity Not Available

TargetMol

Pimecrolimus, a calcineurin inhibitor immunosuppressant, binds to the receptor macrophilin-12 (FKBP-12) forming a complex that blocks the calcium-dependent signal transduction cascade mediated by calcineurin.

More Information Supplier Page

KN-62 100 mg  | 98.77%

TargetMol

KN-62 is a potent and specific Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor with Ki of 0.9 μM.

More Information Supplier Page